Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models

Autor: Dingming Wan, Meng Wang, Hua-yan Zhao, Jing-lan Zhang, Zhongxing Jiang
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Berberine
medicine.medical_treatment
Immunology
Anti-Inflammatory Agents
Graft vs Host Disease
Spleen
Inflammation
Hematopoietic stem cell transplantation
Pharmacology
medicine.disease_cause
Proinflammatory cytokine
Mice
03 medical and health sciences
0302 clinical medicine
Animals
Humans
Immunology and Allergy
Medicine
Bone Marrow Transplantation
Mice
Inbred BALB C
business.industry
NF-kappa B
Total body irradiation
Mice
Inbred C57BL
Disease Models
Animal
Oxidative Stress
surgical procedures
operative
030104 developmental biology
medicine.anatomical_structure
Apoptosis
Lymphocyte Transfusion
030220 oncology & carcinogenesis
Acute Disease
Cyclosporine
Drug Therapy
Combination
Female
Bone marrow
medicine.symptom
business
Immunosuppressive Agents
Oxidative stress
Signal Transduction
Zdroj: International Immunopharmacology. 81:106205
ISSN: 1567-5769
DOI: 10.1016/j.intimp.2020.106205
Popis: Graft-versus-host disease (GVHD) causes significant mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Berberine (BBR) is primarily used to alleviate inflammation caused by autoimmune disorders. Herein the effect of BBR and cyclosporine A (CsA) on GVHD prevention in murine models is explored. Acute GVHD was induced by total body irradiation and tail vein injection with the mixture of bone marrow cells and spleen lymphocytes. Then models were treated with BBR (10 mg/kg), CsA (5 mg/kg) or the combination of BBR and CsA (10 mg/kg and 5 mg/kg) once a day for 10 days. The survival rate, weight loss and GVHD index were monitored. Then the histological changes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, apoptosis and the levels of inflammatory cytokines, oxidative stress and nuclear factor-κB (NF-κB) signaling in liver and intestine were analyzed. Moreover, the levels of inflammatory cytokines and oxidative stress, and the count of T helper 1 (Th1) cells and Th17 cells in peripheral blood were determined. The results showed that BBR reduced GVHD-induced weight loss and GVHD index scores, attenuated liver and intestinal injury, and inhibited ALT and AST activities, inflammation, oxidative stress and NF-κB activation in liver and intestine. Additionally, BBR inhibited inflammation and reduced Th1 cell counts but had no effect on Th17 cell counts. Interestingly, the concomitant therapy of BBR and CsA was more potent than either BBR or CsA and effectively elevated the survival rate of GVHD models. This present study provides a new therapeutic strategy for alleviation of acute GVHD.
Databáze: OpenAIRE
Externí odkaz: